Argos Therapeutics Names Lee Allen Chief Medical Officer

Lee Allen has joined Argos Therapeutics (NASDAQ: ARGS) as the drug developer’s chief medical officer. Allen joins Durham, NC-based Argos as the company continues late-stage clinical trials on a cancer immunotherapy, AGS-003, in kidney cancer. Allen most recently served as chief medical officer for Nevada-based cancer drug company Spectrum Pharmaceuticals (NASDAQ: SPPI). His experience also includes executive positions with AMAG Pharmaceuticals, Wyeth Reseach, Pfizer, and BASF’s Knoll Pharmaceuticals.

 

Frank Vinluan is an Xconomy editor based in Research Triangle Park. You can reach him at fvinluan@xconomy.com. Follow @frankvinluan

Trending on Xconomy